Mark E. Fleury

Also affiliated with Pancreatic Cancer Action Network

MedicineEconomics, Econometrics and FinanceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group”.

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3868

N/A

0.675DataRank · unranked

89 citations

Suanna S. Bruinooge, Harpreet Singh, Keith D. Wilner, Shadia I. Jalal, Stuart M. Lichtman +12 more

Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology

Journal of Clinical Oncology(2024)10.1200/jco.23.01748

N/A

0.524DataRank · unranked

32 citations

Devon Adams, Brittany A. McKelvey, Jeannine S. McCune, Dale Miles, Victoria M. Pratt +5 more